Delivery Order SPE2DB20D2104-SPE2DB24FU02N
- Not listed
- This federal contract award, valued at $1,005.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,183,266 units of Morphine Sulfate Extended-Release 15 mg tablets and has a completion date of April 17, 2025. The contract is a firm-fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Morphine Sulfate Extended Release 30 mg tablets, with a ceiling value of $2,198.61 and a performance period ending on May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Morphine Sulfate Immediate Release 30 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The ceiling value of the Delivery Order is $2,457.60, with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024, with an ultimate completion date of September 4, 2024. This award is not associated with a set-aside program and is part...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,120.56 firm fixed-price delivery order is for 4,563,714,747 units of Morphine Sulfate ER 30 mg capsules. The contract has an ultimate completion date of February 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,963.07 firm fixed-price delivery order is for the supply of 4,568,091,752 units of Morphine Sulfate Extended-Release 10 mg capsules in 100-count bottles. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, with a ceiling value of $3,351.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Morphine Sulfate Extended Release 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at up to $999,999,999.00...
- This federal contract award, valued at $3,359.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 100 tablets of Morphine Sulfate Extended Release 100 mg. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.69 firm fixed price delivery order is for the supply of Morphine Sulfate 4 mg/ml vials. The contract has a completion date of June 21, 2023 and was awarded on June 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award, identified as SPE2DX22D0010|SPE2D825FBE89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,682.83 firm fixed-price delivery order is for the supply of 30mg Morphine Sulfate Extended-Release capsules, with a performance period running through November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,034.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Morphine Sulfate 4 mg/mL vials to support military healthcare programs. The award has an ultimate completion date of January 30, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FU02NDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,335.98 firm-fixed-price delivery order is for the supply of 4,564,536,275 units of Morphine Sulfate Extended-Release 30 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has no set-aside designation, indicating full and open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the efficient procurement of essential prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/6/24 |